Pharma Equity Group Valuation Multiples

Pharma Equity Group Overview

About Pharma Equity Group

Pharma Equity Group AS is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develop technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement. Its drug candidates include RNX-011, RNX-021, RNX-022, RNX-023, RNX-041, and RNX-051 .

Founded

2002

HQ

Employees

5

Website

pharmaequitygroup.com

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: —

EBITDA: ($3M)

EV

$20M

Valuation Multiples

Multiples.vc

Start free trial

Pharma Equity Group Financials

Pharma Equity Group reported last fiscal year revenue of — and negative EBITDA of ($3M).

In the same fiscal year, Pharma Equity Group generated — in gross profit, ($3M) in EBITDA losses, and had net loss of ($3M).

Pharma Equity Group P&L

In the most recent fiscal year, Pharma Equity Group reported revenue of — and EBITDA of ($3M).

Pharma Equity Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

Pharma Equity Group Stock Performance

Pharma Equity Group has current market cap of $17M, and enterprise value of $20M.

Pharma Equity Group's stock price is $0.01.

Pharma Equity Group Valuation Multiples

Pharma Equity Group trades at (6.6x) EV/EBITDA.

Pharma Equity Group Financial Valuation Multiples

As of March 16, 2026, Pharma Equity Group has market cap of $17M and EV of $20M.

Equity research analysts estimate Pharma Equity Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Pharma Equity Group has a P/E ratio of (5.0x).

Pharma Equity Group Margins & Growth Rates

Pharma Equity Group's revenue in the last fiscal year grew by —.

Pharma Equity Group Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Pharma Equity Group M&A Activity

Pharma Equity Group acquired XXX companies to date.

Last acquisition by Pharma Equity Group was on XXXXXXXX, XXXXX. Pharma Equity Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Pharma Equity Group Investment Activity

Pharma Equity Group invested in XXX companies to date.

Pharma Equity Group made its latest investment on XXXXXXXX, XXXXX. Pharma Equity Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).